BriaCell Therapeutics Corp.

BCTXL

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001610820

SEC filings (opens in a new tab)

No open-market purchases or sales by BriaCell Therapeutics Corp. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $2.53M in total; no superinvestor holds it.

Other share classesBCTX BCTXZ

Superinvestors holding BCTXL, Q2 2026

See all superinvestors

No superinvestor reported holding BCTXL in Q2 2026.